Development and validation of a HPTLC method for analysis of Sunitinib malate

Autores

  • Monireh Hajmalek Islamic Azad University; Pharmaceutical Sciences Branch; Young Researchers & Elite Club
  • Masoumeh Goudarzi Tofigh Daru Research and Engineering Company; Quality Control Laboratories; Research & Development Department
  • Solmaz Ghaffari Islamic Azad University; Pharmaceutical Sciences Branch; Pharmaceutical Sciences Research Center
  • Hossein Attar Tofigh Daru Research and Engineering Company; Quality Control Laboratories; Research & Development Department
  • Mehrnoosh Ghanbari Mazlaghan Tofigh Daru Research and Engineering Company; Quality Control Laboratories; Research & Development Department

DOI:

https://doi.org/10.1590/s1984-82502016000400003

Resumo

A simple high performance thin layer chromatography (HPTLC) has been developed and validated for determination of sunitinib malate and possible impurities. The samples were applied in forms of bands on an aluminum TLC plate pre-coated with silica gel and were separated using dichloromethane: methanol: toluene: ammonia solution as the mobile phase. Sunitinib malate was thoroughly separated from impurities including E-isomer, sunitinib N-oxide and impurity B with a retention factor (RF) of 0.35±0.02. Quantitative analysis of sunitinib was carried out using a mobile phase consisting of dichloromethane:methanol:ammonia solution, RF value was 0.53±0.02 for Z isomer. Detection was performed densitometrically in absorbance mode at 430 nm. This method was found to produce sharp, symmetrical, and well resolved peaks. Linear relationship with the coefficients of determination >; 0.99 was achieved over the concentration range of 27.34 to 437.5 ng/spot. This method provides robust, replicable and accurate results with acceptable sensitivity.

Downloads

Os dados de download ainda não estão disponíveis.

Downloads

Publicado

2016-12-01

Edição

Seção

Artigos

Como Citar

Development and validation of a HPTLC method for analysis of Sunitinib malate . (2016). Brazilian Journal of Pharmaceutical Sciences, 52(4), 595-601. https://doi.org/10.1590/s1984-82502016000400003